Healthcare Realty Trust Inc (HR)

AFFO per share data is unavailable; however, FAD (Funds Available for Distribution) shows a 76% payout ratio in Q2 2026, placing the company in the mid-range of safety. Normalized FFO guidance for 2026 is $1.62–$1.66 per share, representing modest growth from 2025 levels, with same-store cash NOI growth of 4.25–5.00% indicating stable operational performance. The dividend of $0.24 per share per quarter has been maintained and recently approved, but the filing provides no evidence of a 10+ year growth streak or accelerating AFFO growth. The 76% payout ratio and flat-to-modest FFO growth align with a score of 3—dividend is secure and maintained, but not demonstrating the steady AFFO growth and lower payout ratios characteristic of a score of 5.

Net debt/EBITDA of 5.6x sits at the upper boundary of the 5-5.5x range, placing HR between the 5-anchor and 3-anchor. The company demonstrated proactive balance sheet management by issuing $700 million of 3.00% exchangeable notes due 2032 to refinance $600 million of near-term 2026 debt, eliminating a maturity wall and extending the debt ladder. The 3.00% fixed rate and 2032 maturity represent favorable terms and reduced refinancing risk. With $1.6 billion of liquidity and a newly secured $400 million delayed draw term loan maturing in 2029, the company has substantial cushion and manageable near-term maturities. While leverage is elevated relative to the 5-anchor threshold, the fixed-rate debt profile, extended maturity ladder, and strong liquidity position support a score above the 3-anchor.

Healthcare Realty demonstrates strong operating performance with same-store cash NOI growth of 5.1% in Q2 2026, exceeding the 3% threshold for a score of 5. Occupancy stands at 90.7%, which is stable in the low 90s range but falls short of the 95%+ requirement for a top score. Leasing spreads are positive at 4.8% cash spreads with 3.0% average annual escalators, indicating healthy pricing power. The company raised full-year 2026 guidance to 4.25%-5.00% same-store cash NOI growth, demonstrating consistent momentum. While occupancy remains slightly below the 95%+ anchor, the combination of strong NOI growth, positive spreads, and stable occupancy in the low 90s aligns with upper-tier performance.

Healthcare Realty operates in the healthcare real estate sector, which benefits from secular tailwinds driven by aging demographics and healthcare spending growth, supporting a score above the midpoint. The portfolio demonstrates moderate tenant quality with relationships to large health systems (CommonSpirit, Ascension, Yale New Haven Health, Wellstar) and a 90.7% occupancy rate indicating stable operations. However, the REIT shows moderate concentration risk with significant exposure to a few large anchor tenants and a weighted average lease term of 5.7 years that is respectable but not exceptionally long. Assets appear reasonably modern given recent acquisitions and redevelopment activity, though the company operates in competitive markets without clear supply constraints. The 5.6x net debt-to-EBITDA leverage and recent capital raises suggest financial management is adequate but not exceptional, placing the portfolio quality solidly in the stable, competitive middle range.

HR demonstrates mixed capital allocation discipline with concerning dilutive patterns. While the company repurchased 3.8 million shares ($75 million) concurrent with the exchangeable notes issuance and entered capped call transactions to limit dilution, the $700 million exchangeable notes offering at $23.01 per share (near current price of $21.34) represents potential future dilution. The company's FFO per share grew modestly from $0.34 to $0.36 year-over-year despite significant acquisition activity, and guidance raises suggest asset growth without clear per-share accretion. Joint venture acquisitions at 7.5% yields and dispositions at sub-5% cap rates show selective capital discipline, but the overall pattern reflects growth-focused rather than per-share-focused allocation. Disclosure is adequate but lacks candid commentary on dilution trade-offs.

Valuation scored against the same-category peer cross-section (peer_fallback) from this nightly pass, because this name has fewer than 8 own-history points so far.